RichardNicholasFormicaMD
Nephrology • New Haven, CTProfessor of Medicine and Surgery, Yale University
Dr. Formica is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Cedar Street
Boardman 124, P.O. Box 208029
New Haven, CT 06520Phone+1 203-785-2565Fax+1 203-688-3068
Education & Training
Yale-New Haven Medical CenterFellowship, Nephrology, 1997 - 1999
Boston University Medical CenterResidency, Internal Medicine, 1993 - 1996
Boston University School of MedicineClass of 1993
Certifications & Licensure
RI State Medical License 2023 - 2026
CT State Medical License 1998 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Noninvasive Methods to Monitor Graft Survival in Kidney Transplant Patients Start of enrollment: 2006 Mar 01
- Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation Start of enrollment: 2010 Nov 01
- Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation Start of enrollment: 2023 Dec 07
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 46 citationsDiscovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant RejectionRania El Fekih, James Hurley, Vasisht Tadigotla, Areej Alghamdi, Anand Srivastava
Journal of the American Society of Nephrology. 2021-03-03 - 551 citationsAssociation between delayed graft function and allograft and patient survival: a systematic review and meta-analysisSri G. Yarlagadda, Steven G. Coca, Richard N. Formica, Emilio D. Poggio, Chirag R. Parikh
Nephrology, Dialysis, Transplantation. 2008-12-22 - 44 citationsSafety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant.Robert R. Redfield, Stanley C. Jordan, Stephan Busque, Flavio Vincenti, E. Steve Woodle
American Journal of Transplantation. 2019-11-01
Journal Articles
- Report of National Kidney Foundation Consensus Conference to Decrease Kidney DiscardsStephen Pastan, John Friedewald, Sumit Mohan, Ryutaro Hirose, Richard Formica, Clinical Transplantation
Press Mentions
Transplant Surgeons Allege Corruption and Mismanagement in Organ Transplant SystemSeptember 13th, 2024- Major Organ Center in Waltham Flagged over Low Donation NumbersMay 4th, 2023
- US Counts Millionth Organ Transplant While Pushing for MoreSeptember 9th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
